Originally published on Fri October 19, 2012 3:54 pm
"It was the best of times, it was the best of times," riffs aspiring writer Sophia in the opening of MTV's new dramedy, Underemployed, as she taps away on her laptop, narrating the lives of her recent-grad friends a la Carrie Bradshaw. It's the first cliché in a series full of them. It's also a sign of the ongoing fascination with the lives of twentysomethings trying and failing to do big things in big cities during a big recession. (Take it from me — it's not that great.)
Originally published on Thu October 18, 2012 1:21 pm
Gathering voters to watch a presidential debate and then evaluate it is a long tradition in American journalism. So, I got to thinking: What would happen if I invited a bunch of interested foreigners — all of them Chinese citizens — to watch the presidential debate from my Shanghai office?
An Indian child receives the oral polio vaccine. Twice a year, an army of 2 million volunteers fans out across India to administer the vaccine. India has not reported a single case of polio in more than a year-and-a-half.
Credit Julie McCarthy / NPR
Dr. Kiran Kathuria (left) and veteran volunteer Santosh Sharma (front right) make the rounds with a team of vaccinators in Nehru Nagar, a middle-class area of Delhi. India's nationwide polio eradication program, begun in 1995, was modeled after Delhi's.
All this week, we've been examining the world's last remaining pockets of polio, a disease for which there is no cure. India marked a milestone when the World Health Organization struck it from the list of polio-endemic countries in February after no new cases were reported for more than a year. From Delhi, NPR's Julie McCarthy reports on how, despite poverty and poor sanitation, the world's second-most populous country is eradicating the disease.
Originally published on Thu October 18, 2012 12:04 pm
A small study offers a bit of cautious optimism about the prospects for treatment of tuberculosis, one of humankind's most ancient scourges.
This week's New England Journal of Medicine has a report showing that adding a 12-year-old antibiotic called linezolid, brand name Zyvox, to existing treatments cured nearly 90 percent of patients with a form of tuberculosis resistant to both first- and second-line antibiotics.